Archive for February 2022

Good morning, Boston. Here are the five things you need to know to start your busy workday, and who I’m rooting for in the Super Bowl. Read More

Cambridge biotech Akebia Therapeutics donates money to the National Kidney Foundation, its employees raise money for it, and many of them volunteer for the organization as well. Read More

The commitment gives the still-under-construction tower, which will be one of Boston’s tallest, its first known large office tenant. Read More

Plenty of headlines over the past two years have included some variation of the question: who needs office space anymore? But the numbers show that companies are still snatching up Boston area office, industrial and lab space at dizzying rates. Read More

When it comes to business stories about the pandemic, headlines have often included some variation of the question: who needs office space anymore? But companies are still snatching up office space — and industrial space and, of course, lab space. Read More

Baker’s plan would use some funding from the federal infrastructure law and $1.25 billion from last year’s transportation bond bill. Read More

The gene editing firm is buying a little-known University of California-Berkeley spinout called Rewrite Therapeutics in a deal worth up to $200 million. Read More

A team of MIT experts working with the Federal Reserve Bank of Boston have released early findings of research through which Central Bank Digital Currency (CBDC) research could be performed in the U.S. Read More

“Many workers used to work in cubicles. Now it’s becoming a little bit more like bench seating … People would like to be in an office environment that is a little bit warmer in terms of color, lighting and finishes than we are used to seeing," said Tin Min Fong, director of technical development at…